S Imai
About
In The Last Decade
S Imai
19 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 60
- Oncology 980
- Pathology and Forensic Medicine 593
- Immunology 313
- Infectious Diseases 188
- Epidemiology 175
Countries citing papers authored by S Imai
This map shows the geographic impact of S Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Imai more than expected).
Fields of papers citing papers by S Imai
This network shows the impact of papers produced by S Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Imai. The network helps show where S Imai may publish in the future.
Co-authorship network of co-authors of S Imai
This figure shows the co-authorship network connecting the top 25 collaborators of S Imai. A scholar is included among the top collaborators of S Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Imai. S Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 8 | |
| 3 | 5 | |
| 4 | 41 | |
| 5 | 29 | |
| 6 | [Clinical, phenotypic and genotypic aspects of nasal T-cell lymphoma and its causal association with Epstein-Barr virus]. | 1 |
| 7 | 170 | |
| 8 | Cryptic dysfunction of cellular immunity in asymptomatic human immunodeficiency virus (HIV) carriers and its actualization by an environmental immunosuppressive factor. | 5 |
| 9 | Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in family members of adult T-cell leukemia (ATL) patients in non-ATL-endemic Hokkaido of Japan. | 1 |
| 10 | Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in general inhabitants in non-adult T-cell leukemia (ATL)-endemic Hokkaido, Japan. | 3 |
| 11 | 377 | |
| 12 | 1 | |
| 13 | Detection of Epstein-Barr virus genome in cerebrospinal fluid from a patient with acquired chorea by the polymerase chain reaction. | 1 |
| 14 | Epstein-Barr virus in adult T-cell leukemia/lymphoma. | 42 |
| 15 | 7 | |
| 16 | 450 | |
| 17 | 5 | |
| 18 | [Virological and immunological studies on inapparent Epstein-Barr virus infection in healthy individuals: in comparison to immunosuppressed patients and patients with infectious mononucleosis]. | 6 |
| 19 | Epstein-Barr virus infection and oncogenesis in primary immunodeficiency. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.